Abstract:The comet assay offers the opportunity to measure both DNA damage and repair. Various comet assay based methods are available to measure DNA repair activity, but some requirements should be met for their effective use in human biomonitoring studies. These conditions include i) robustness of the assay, ii) sources of inter- and intra-individual variability must be known, iii) DNA repair kinetics should be assessed to optimize sampling timing; and iv) DNA repair in accessible surrogate tissues should reflect repair activity in target tissues prone to carcinogenic effects. DNA repair phenotyping can be performed on frozen and fresh samples, and is a more direct measurement than genomic or transcriptomic approaches. There are mixed reports concerning the regulation of DNA repair by environmental and dietary factors. In general, exposure to genotoxic agents did not change base excision repair (BER) activity, whereas some studies reported that dietary interventions affected BER activity. On the other hand, in vitro and in vivo studies indicated that nucleotide excision repair (NER) can be altered by exposure to genotoxic agents, but studies on other life style related factors, such as diet, are rare. Thus, crucial questions concerning the factors regulating DNA repair and inter-individual variation remain unanswered. Intra-individual variation over a period of days to weeks seems limited, which is favourable for DNA repair phenotyping in biomonitoring studies. Despite this reported low intra-individual variation, timing of sampling remains an issue that needs further investigation. A correlation was reported between the repair activity in easily accessible peripheral blood mononuclear cells (PBMCs) and internal organs for both NER and BER. However, no correlation was found between tumour tissue and blood cells. In conclusion, although comet assay based approaches to measure BER/NER phenotypes are feasible and promising, more work is needed to further optimize their application in human biomonitoring and intervention studies.

An optimized comet-based in vitro DNA repair assay to assess base and nucleotide excision repair activity

The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations

DNA repair as a human biomonitoring tool: Comet assay approaches

Alkaline Comet Assay for Assessing DNA Damage in Individual Cells

The comet assay: a method to measure DNA damage in individual cells

DNA Probes for Analysis the Activity of Key Enzymes of the Base Excision DNA Repair Pathway in Human Cells

The comet assay: what can it really tell us?

A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase

A new approach utilizing real-time qPCR to detect in vitro base excision repair.

Assays to Determine DNA Repair Ability

Measuring DNA modifications with the comet assay: a compendium of protocols

Assessment of Human DNA Repair (NER) Capacity with DNA Repair Rate (DRR) by Comet Assay.

Technical recommendations to perform the alkaline standard and enzyme-modified comet assay in human biomonitoring studies

Detection of DNA Breaks in Dividing Human Cells by Neutral Comet Assay

The comet assay: topical issues

Direct Evaluation of Single-strand Break Repair Capacity of Cells Using a Pyrene Excimer-based Hairpin Probe

Chimeric d/l-DNA Probes of Base Excision Repair Enable Real-Time Monitoring of Thymine DNA Glycosylase Activity in Live Cells

Development of a rapid, small-scale DNA repair assay for use on clinical samples

[Detecting DNA Repair Capacity of Human Lymphocytes Exposed to Ultraviolet C with Comet Assay].

DNA damage and repair measured by comet assay in cancer patients

Comet Assay measurements: a perspective